Overview

Tranexamic Acid in Gender Mastectomy

Status:
Suspended

Trial end date:
2022-11-01

Target enrollment:

Participant gender:

Summary

The goal of this study is to examine the use of tranexamic acid (TXA) in gender mastectomy surgery, specifically looking at volume loss (blood and transudate) postoperatively.

Phase:

Phase 4

Details

Lead Sponsor:

University of Wisconsin, Madison

Treatments:

Tranexamic Acid